ENTRY       D11984                      Drug
NAME        Cevostamab (USAN/INN)
FORMULA     C6508H10063N1727O2027S40
EXACT_MASS  146121.6269
MOL_WEIGHT  146211.4905
SEQUENCE    (A chain)
            EVQLVESGPG LVKPSETLSL TCTVSGFSLT RFGVHWVRQP PGKGLEWLGV IWRGGSTDYN
            AAFVSRLTIS KDNSKNQVSL KLSSVTAADT AVYYCSNHYY GSSDYALDNW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYG
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLWC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
            (B chain)
            EVQLVQSGAE VKKPGASVKV SCKASGFTFT SYYIHWVRQA PGQGLEWIGW IYPENDNTKY
            NEKFKDRVTI TADTSTSTAY LELSSLRSED TAVYYCARDG YSRYYFDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYGS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLSCA VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLVS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (C chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQDVR NLVVWFQQKP GKAPKLLIYS GSYRYSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ HYSPPYTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (D chain)
            DIVMTQSPDS LAVSLGERAT INCKSSQSLL NSRTRKNYLA WYQQKPGQSP KLLIYWTSTR
            KSGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCKQSFIL RTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: A22-A95, A147-A203, A223-D214, A229-B228, A232-B231, A264-A324, A370-A428, B22-B96, B146-B202, B222-C219, B263-B323, B369-B427, C23-C94, C139-C199, D23-D88, D134-D194)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      FCRL5 [HSA:83416] [KO:K06727]
            CD3E [HSA:916] [KO:K06451]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11984  Cevostamab (USAN/INN)
             Not elsewhere classified
              Organismal systems
               Immune system
                FCRL5
                 D11984  Cevostamab (USAN/INN)
DBLINKS     CAS: 2249888-53-5
///
